These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6146548)

  • 21. Chronic effects of caerulein and secretin on the endocrine pancreas of the rat.
    Yamada T; Brunstedt J; Solomon T
    Am J Physiol; 1983 May; 244(5):G541-5. PubMed ID: 6133454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased release of somatostatin into the portal vein following electrical vagal stimulation in the cat.
    Uvnäs-Wallensten K; Efendic S; Roovete A; Johansson C
    Acta Physiol Scand; 1980 Aug; 109(4):393-8. PubMed ID: 6110310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of somatostatin and calcium deprivation on cholecystokinin or caerulein-induced insulin and glucagon release from the isolated perfused rat pancreas.
    Otsuki M; Sakamoto C; Yun H; Maeda M; Morita S; Baba S
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():95-102. PubMed ID: 6112142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of somatostatin following a test meal in dogs. Initial atropine resistant vagally mediated decrease of somatostatin levels and increase of gastrin and insulin levels.
    Uvnäs-Moberg K; Andersson B; Posloncec B
    Acta Physiol Scand; 1982 Feb; 114(2):253-9. PubMed ID: 6127867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin: a potential antigrowth factor for the exocrine pancreas.
    Morisset J
    Regul Pept; 1984 Dec; 10(1):11-22. PubMed ID: 6085177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of exocrine pancreatic secretion by somatostatin in dogs.
    Susini C; Esteve JP; Bommelaer G; Vaysse N; Ribet A
    Digestion; 1978; 18(5-6):384-93. PubMed ID: 750262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of acid formation and stimulation of somatostatin release by cholecystokinin-related peptides in rabbit gastric glands.
    Bengtsson P; Lundqvist G; Nilsson G
    J Physiol; 1989 Dec; 419():765-74. PubMed ID: 2576071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog.
    de Jong AJ; Singer MV; Jansen JB; Niebel W; Rovati LC; Lamers CB
    Gut; 1991 Feb; 32(2):215-9. PubMed ID: 1864545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Caerulein and the test meal: a comparison of their effects on pancreatic exocrine secretion in the dog].
    Meyer FD; Gyr K; Kayasseh L; Rittmann WW; Stalder GA; Girard J
    Schweiz Med Wochenschr; 1979 Apr; 109(16):599-600. PubMed ID: 432588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoreactive somatostatin in rat hypophysial portal blood.
    Gillioz P; Giraud P; Conte-Devolx B; Jaquet P; Codaccioni JL; Oliver C
    Endocrinology; 1979 May; 104(5):1407-10. PubMed ID: 436785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of corticotropin-releasing factor on plasma motilin and somatostatin levels and gastrointestinal motility in dogs.
    Bueno L; Fargeas MJ; Gue M; Peeters TL; Bormans V; Fioramonti J
    Gastroenterology; 1986 Oct; 91(4):884-9. PubMed ID: 2875010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatostatin modulation of peptide-induced acetylcholine release in guinea pig ileum.
    Teitelbaum DH; O'Dorisio TM; Perkins WE; Gaginella TS
    Am J Physiol; 1984 May; 246(5 Pt 1):G509-14. PubMed ID: 6202156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of gastrin on circulating levels of somatostatin, pancreatic polypeptide, and vasoactive intestinal peptide in dogs.
    Guzman S; Lonovics J; Chayvialle JA; Hejtmancik KE; Rayford PL; Thompson JC
    Endocrinology; 1980 Jul; 107(1):231-6. PubMed ID: 6103802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of synthetic somatostatin on canine pancreatic exocrine secretion and its comparison with a duodenal somatostatin-like immunoreactive (SLI) extract.
    Susini C; Bommelaer G; Esteve J; Pradayrol L; Vaysse N
    Metabolism; 1978 Sep; 27(9 Suppl 1):1341-4. PubMed ID: 682998
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of low amine diet on gastric endocrine cell proliferation in the rat.
    Mulholland MW; Delaney JP
    J Surg Res; 1988 Aug; 45(2):215-21. PubMed ID: 2900348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin 1-28 circulates in human plasma.
    Baldissera FG; Munoz-Perez MA; Holst JJ
    Regul Pept; 1983 Apr; 6(1):63-9. PubMed ID: 6191365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33.
    Solomon TE; Yamada T; Elashoff J; Wood J; Beglinger C
    Am J Physiol; 1984 Jul; 247(1 Pt 1):G105-11. PubMed ID: 6204542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Half-life of somatostatin-like immunoreactivity in canine plasma.
    Schusdziarra V; Harris V; Unger RH
    Endocrinology; 1979 Jan; 104(1):109-10. PubMed ID: 446338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatostatin 28: effects on exocrine pancreatic secretion in conscious dogs.
    Susini C; Esteve JP; Vaysse N; Pradayrol L; Ribet A
    Gastroenterology; 1980 Oct; 79(4):720-4. PubMed ID: 7409390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of somatostatin on myoelectrical activity of small bowel.
    Thor P; Król R; Konturek SJ; Coy DH; Schally AV
    Am J Physiol; 1978 Sep; 235(3):E249-54. PubMed ID: 696818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.